🔗 Permalink

Inventor profile of:

Dwight D. Weller

City:

Corvallis, Oregon

Country:

United States

Published Applications:

Last publication date:

2022-04-28

Top Assignees for applications by Dwight D. Weller

The entities that hold a legal rights for patent applications filed by inventor Weller Dwight D.:

AVI BIOPHARMA, INC. 24 Corvallis, OR United States
Sarepta Therapeutics, Inc. 17 Corvallis, OR United States
Sarepta Therapeutics, Inc. 7 Cambridge, MA United States
U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND 2 FREDERICK, MD United States
The Scripps Research Institute 1 La Jolla, CA United States
The United States of America as represented by the Army Medical Research and Material Command 1 Washington, DC United States

Recent patent applications by Weller Dwight D.

Dwight D. Weller from Corvallis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-04-28

US20220127613A1

Chemistry; metallurgy

Functionally-Modified Oligonucleotides And Subunits Thereof

#2 | 2021-05-13

US20210139911A1

Chemistry; metallurgy

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

#3 | 2020-04-16

US20200115709A1

Chemistry; metallurgy

Functionally-modified oligonucleotides and subunits thereof

#4 | 2018-08-09

US20180223278A1

Chemistry; metallurgy

Functionally-modified oligonucleotides and subunits thereof

#5 | 2017-10-26

US20170306323A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#6 | 2017-08-31

US20170247410A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#7 | 2017-07-13

US20170198287A1

Chemistry; metallurgy

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#8 | 2016-12-29

US20160376587A1

Chemistry; metallurgy

Functionally-modified oligonucleotides and subunits thereof

#9 | 2016-09-01

US20160251398A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#10 | 2015-10-01

US20150275204A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#11 | 2015-09-24

US20150267202A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ss/RNA viral infection

#12 | 2015-07-02

US20150184165A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#13 | 2015-05-07

US20150126722A1

Chemistry; metallurgy

OLIGONUCLEOTIDE COMPOUND AND METHOD FOR TREATING NIDOVIRUS INFECTIONS

#14 | 2015-04-30

US20150119316A1

Chemistry; metallurgy

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

#15 | 2015-03-12

US20150073140A1

Chemistry; metallurgy

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#16 | 2014-11-06

US20140330006A1

Chemistry; metallurgy

Functionally-modified oligonucleotides and subunits thereof

#17 | 2014-07-31

US20140213737A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#18 | 2014-07-10

US20140194612A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#19 | 2014-02-13

US20140044750A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#20 | 2013-05-23

US20130131312A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

#21 | 2013-01-10

US20130011420A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#22 | 2012-12-20

US20120322847A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ssRNA viral infection

#23 | 2012-03-15

US20120065169A1

Chemistry; metallurgy

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#24 | 2012-02-09

US20120035136A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#25 | 2011-07-14

US20110172418A1

Chemistry; metallurgy

ANTISENSE RESTENOSIS COMPOSITION AND METHOD

#26 | 2011-07-07

US20110166082A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#27 | 2010-09-16

US20100234281A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#28 | 2010-06-03

US20100137408A1

Chemistry; metallurgy

ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND

#29 | 2009-07-23

US20090186849A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#30 | 2009-07-23

US20090186848A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#31 | 2009-07-23

US20090186847A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#32 | 2009-05-21

US20090131632A1

Chemistry; metallurgy

Method of synthesis of morpholino oligomers

#33 | 2009-05-21

US20090131624A1

Chemistry; metallurgy

Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits

#34 | 2009-04-30

US20090110689A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#35 | 2009-04-02

US20090088562A1

Chemistry; metallurgy

Oligonucleotide analogs having cationic intersubunit linkages

#36 | 2009-01-08

US20090012280A1

Chemistry; metallurgy

Oligonucleotide compound and method for treating nidovirus infections

#37 | 2008-08-14

US20080194463A1

Chemistry; metallurgy

Antibacterial antisense oligonucleotide and method

#38 | 2008-07-31

US20080182973A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

#39 | 2007-11-15

US20070265215A1

Chemistry; metallurgy

Antisense restenosis composition and method

#40 | 2007-11-15

US20070265214A1

Human necessities

Antisense antiviral agent and method for treating ssRNA viral infection

#41 | 2007-09-04

US9943458

Method for analysis of oligonucleotide analogs

#42 | 2007-06-07

US20070129323A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating picornavirus infection

#43 | 2007-05-31

US20070122821A1

Chemistry; metallurgy

Antisense composition and method for treating muscle atrophy

#44 | 2007-05-17

US20070111962A1

Chemistry; metallurgy

Immunosuppression compound and treatment method

#45 | 2007-03-22

US20070066556A1

Human necessities

Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

#46 | 2007-03-01

US20070049542A1

Chemistry; metallurgy

Antisense antibacterial method and compound

#47 | 2007-02-15

US20070037764A1

Human necessities

Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

#48 | 2007-02-15

US20070037763A1

Chemistry; metallurgy

Oligonucleotide compound and method for treating nidovirus infections

#49 | 2007-01-04

US20070004661A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating influenza viral infection

#50 | 2006-12-28

US20060293268A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating foot and mouth disease

#51 | 2006-12-21

US20060287268A1

Chemistry; metallurgy

Splice-region antisense composition and method

#52 | 2006-12-14

US20060281701A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#53 | 2006-12-07

US20060276425A1

Human necessities

Antisense oligomers and methods for inducing immune tolerance and immunosuppression

#54 | 2006-11-30

US20060269911A1

Chemistry; metallurgy

Antisense antiviral compound and method for treating ssRNA viral infection

#55 | 2006-11-30

US20060269587A1

Human necessities

Antisense restenosis composition and method

#56 | 2006-08-22

US9493427

Antisense restenosis composition and method

#57 | 2005-12-29

US20050288246A1

Chemistry; metallurgy

Peptide conjugated, inosine-substituted antisense oligomer compound and method

InventorID:

27121 ⎘